pubmed-article:21503302 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0334227 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0596290 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0028621 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0040077 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0025723 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0182400 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0439831 | lld:lifeskim |
pubmed-article:21503302 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
pubmed-article:21503302 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:21503302 | pubmed:dateCreated | 2011-5-19 | lld:pubmed |
pubmed-article:21503302 | pubmed:abstractText | Pd(0)-mediated rapid couplings of CH(3)I (and then [(11)C]CH(3)I) with excess 5-tributylstannyl-2'-deoxyuridine and -4'-thio-2'-deoxyuridine were investigated for the syntheses of [methyl-(11)C]thymidine and its stable analogue, 4'-[methyl-(11)C]thiothymidine as PET probes for cancer diagnosis. The previously reported conditions were attempted using Pd(2)(dba)(3)/P(o-CH(3)C(6)H(4))(3) (1?:?4 in molar ratio) at 130 °C for 5 min in DMF, giving desired products only in 32 and 30% yields. Therefore, we adapted the current reaction conditions developed in our laboratory for heteroaromatic compounds. The reaction using CH(3)I/stannane/Pd(2)(dba)(3)/P(o-CH(3)C(6)H(4))(3)/CuCl/K(2)CO(3) (1?:?25?:?1?:?32?:?2?:?5) at 80 °C gave thymidine in 85% yield. Whereas, CH(3)I/stannane/Pd(2)(dba)(3)/P(o-CH(3)C(6)H(4))(3)/CuBr/CsF (1?:?25?:?1?:?32?:?2?:?5) including another CuBr/CsF system promoted the reaction at a milder temperature (60 °C), giving thymidine in 100% yield. Chemo-response of thiothymidine-precursor was different from thymidine system. Thus, the above optimized conditions including CuBr/CsF system gave 4'-thiothymidine only in 40% yield. The reaction using 5-fold amount of CuBr/CsF at 80 °C gave much higher yield (83%), but unexpectedly, the reaction was accompanied by a considerable amount of undesired destannylated product. Such destannylation was greatly suppressed by changing to a CuCl/K(2)CO(3) system using CH(3)I/stannane/Pd(2)(dba)(3)/P(o-CH(3)C(6)H(4))(3)/CuCl/K(2)CO(3) (1?:?25?:?1?:?32?:?2?:?5) at 80 °C, giving the 4'-thiothymidine in 98% yield. The each optimized conditions were successfully applied to the syntheses of the corresponding PET probes in 87 and 93% HPLC analytical yields. [(11)C]Compounds were isolated by preparative HPLC after the reaction conducted under slightly improved conditions, exhibiting sufficient radioactivity of 3.7-3.8 GBq and specific radioactivity of 89-200 GBq µmol(-1) with radiochemical purity of ?99.5% for animal and human PET studies. | lld:pubmed |
pubmed-article:21503302 | pubmed:language | eng | lld:pubmed |
pubmed-article:21503302 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21503302 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21503302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21503302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21503302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21503302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21503302 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21503302 | pubmed:month | Jun | lld:pubmed |
pubmed-article:21503302 | pubmed:issn | 1477-0539 | lld:pubmed |
pubmed-article:21503302 | pubmed:author | pubmed-author:SuzukiMasaaki... | lld:pubmed |
pubmed-article:21503302 | pubmed:author | pubmed-author:Siqin | lld:pubmed |
pubmed-article:21503302 | pubmed:author | pubmed-author:DoiHisashiH | lld:pubmed |
pubmed-article:21503302 | pubmed:author | pubmed-author:SumiKengoK | lld:pubmed |
pubmed-article:21503302 | pubmed:author | pubmed-author:ZhangZhouenZ | lld:pubmed |
pubmed-article:21503302 | pubmed:author | pubmed-author:KoyamaHirokoH | lld:pubmed |
pubmed-article:21503302 | pubmed:author | pubmed-author:NagataHirokoH | lld:pubmed |
pubmed-article:21503302 | pubmed:author | pubmed-author:HattaYumaY | lld:pubmed |
pubmed-article:21503302 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21503302 | pubmed:day | 7 | lld:pubmed |
pubmed-article:21503302 | pubmed:volume | 9 | lld:pubmed |
pubmed-article:21503302 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21503302 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21503302 | pubmed:pagination | 4287-94 | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:meshHeading | pubmed-meshheading:21503302... | lld:pubmed |
pubmed-article:21503302 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21503302 | pubmed:articleTitle | Highly efficient syntheses of [methyl-11C]thymidine and its analogue 4'-[methyl-11C]thiothymidine as nucleoside PET probes for cancer cell proliferation by Pd(0)-mediated rapid C-[11C]methylation. | lld:pubmed |
pubmed-article:21503302 | pubmed:affiliation | Division of Regeneration and Advanced Medical Science, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu, 501-1193, Japan. | lld:pubmed |
pubmed-article:21503302 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21503302 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |